AroCell Q4: Nearing positive operating cash flow

Research Update

2024-02-23

13:48

Redeye leaves its estimates and valuation untouched following the report. However, our gross margin assumptions might be reconsidered (downward) if the coming quarters do not show better gross margin development.

OB

Oscar Bergman

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.